Testing, Treating, and Targeting Triple Negative Breast Cancer | 2023 West Oncology Conference

Navigating the Expanding Treatment Arsenal for ER+/HER2- Breast CancerПодробнее

Neoadjuvant Immunotherapy in TNBC and Targeted LND in Breast Cancer: 2023 Best of Breast ConferenceПодробнее

TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment ArsenalПодробнее

Future Challenges and Opportunities in Community Oncology | 2023 West Oncology ConferenceПодробнее

Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology ConferenceПодробнее

Treatment Planning for Triple Negative Breast Cancer | 2022 Evolution ConferenceПодробнее

Issues in Triple Negative Breast Cancer: 2023 Best of Breast ConferenceПодробнее

Testing and Targeted Therapy in Triple Negative Breast Cancer: 2023 West OncologyПодробнее

Metastatic Triple Negative Breast Cancer: 2023 Best of Breast ConferenceПодробнее

2022 West Oncology Conference | Precision Oncology in HR+ Breast CancerПодробнее

2022 West Oncology Conference | Breast Cancers | MetastaticПодробнее

Lightning Updates | 2023 Best of Breast ConferenceПодробнее

Geriatric Oncology | 2023 West Oncology ConferenceПодробнее

Recent developments in treating TNBC with targeted therapiesПодробнее

2022 West Oncology Conference | Breast Cancers | Early-StageПодробнее

Utilizing Actionable Classifications in TNBCПодробнее

Harnessing the Immune System in the Treatment of Triple-Negative Breast CancerПодробнее

TNBC Current and Emerging Therapeutic Strategies | 2023 Best of Breast ConferenceПодробнее

Adjuvant Therapy | 2023 Best of Breast ConferenceПодробнее

2022 West Oncology Conference | Breast Cancers | Q&A and Panel DiscussionПодробнее